| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/1999 | CN1041939C Androstenones |
| 02/03/1999 | CN1041938C Triterpene derivatives and endothelin-receptor antagonists containing the same |
| 02/03/1999 | CN1041937C Androstane derivatives and pharmaceutical composition containing them and process for preparing same |
| 02/03/1999 | CN1041935C Benzo [f] quinoxalindione derivative, their use in medicine |
| 02/03/1999 | CN1041934C Process for preparing and/or purifying bar acid or medicinal salt or ester thereof |
| 02/03/1999 | CN1041933C Diamine salts of clavulanic acid and their preparation process and use |
| 02/03/1999 | CN1041931C [1,2,4] trizolo [4,3,-a] quinoxaline compounds, their preparation and use |
| 02/03/1999 | CN1041930C [1,2,4] triazolo [4,3-1] quinoxaline derivatives, their preparation and use |
| 02/03/1999 | CN1041929C Heterocyclic derivatives and preparation process and use thereof, medicinal composition containing same |
| 02/03/1999 | CN1041928C Imidazoloquinoxalinone and preparation process and use thereof |
| 02/03/1999 | CN1041925C (S)-(+)-5-amino-2,4,6,7-tetramethyl-2-(4-phenyl piperidyl)-2,3-dihydrobenzo (6) furan crystal and use |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/03/1999 | CN1041921C Bicyclic fibrinogen antagonists |
| 02/03/1999 | CN1041920C Glycerin derivative and its pharmacological use |
| 02/03/1999 | CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/03/1999 | CN1041894C Aerosols for protective film of medicine 'Hemostatic-Yantongting' |
| 02/02/1999 | USRE36080 Therapy sickle cell anemia |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866703 With at least two different acids chosen from 6-desaturated essential fatty acids and oleic acid, useful in nutrition and in medicine. |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866699 Oligonucleotides with anti-MDR-1 gene activity |
| 02/02/1999 | US5866617 Aqueous solution for administration to patients also receiving cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866616 3,3-(disubstituted) cyclohexan-1-ol monomers and related compounds |
| 02/02/1999 | US5866615 Lyophilized formulation with anticancer agents; reduced side effects, increased activity |
| 02/02/1999 | US5866613 Diethyltris/trimethylene/tetramine and salts |
| 02/02/1999 | US5866612 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase |
| 02/02/1999 | US5866611 Phenoxypropylamine inhibitors of squalene synthese, useful in treating diseases in which a lowering of cholesterol is desirable. |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866607 2-hydroxy- or 2-bromo-fatty acids |
| 02/02/1999 | US5866606 Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents |
| 02/02/1999 | US5866605 Method for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockers |
| 02/02/1999 | US5866604 Thiol derivatives with metallopeptidase inhibitory activity |
| 02/02/1999 | US5866602 Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 02/02/1999 | US5866600 Administering amtolmetin guacyl |
| 02/02/1999 | US5866598 4h-carbazol-4-ones |
| 02/02/1999 | US5866597 Use of triazine compounds for the treatment of memory and learning disorders |
| 02/02/1999 | US5866595 Calcium antagonists for treatment of vascular restenosis |
| 02/02/1999 | US5866593 Potent and selective phosphodiesterase type iv inhibitors, useful in the prophylaxis and treatment of diseases such as asthma where an unwanted inflammatory response or muscular spasm is present. |
| 02/02/1999 | US5866591 Stable formulations of remifentanil |
| 02/02/1999 | US5866590 Ascorbic acid or a-tocopherol and ascorbyl palmitate as oxidative stabilizers |
| 02/02/1999 | US5866589 Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866587 Hydroxamide derivatives of fused piperidine derivatives |
| 02/02/1999 | US5866586 CNS-active pyridinylurea derivatives |
| 02/02/1999 | US5866585 Methods of treating tardive dyskinesia using NMDA receptor antagonists |
| 02/02/1999 | US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. |
| 02/02/1999 | US5866583 Substituted 2,4-diaminopyrimidines |
| 02/02/1999 | US5866581 Penciclovir for the treatment of post therapeutic neuralgia |
| 02/02/1999 | US5866579 Imidazole and imidazoline derivatives and uses thereof |
| 02/02/1999 | US5866578 Substituted pyrimidines for control of diabetic complications |
| 02/02/1999 | US5866577 Aromatic amidine derivatives and salts thereof |
| 02/02/1999 | US5866574 Administering an effective amount of an adenosine uptake inhibitor |
| 02/02/1999 | US5866571 Treatment of inflammations, thromboembolic diseases and cardiovascular diseases. |
| 02/02/1999 | US5866570 Treatment of vascular leakage and related syndrome such as septic shock by administration of metalloproteinase inhibitors |
| 02/02/1999 | US5866569 Naphthalenedione nitric oxide synthase (NOS) inhibitors |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866566 Derivatives of 10, 11-Dihydro-10-OXO-5H-Dibenz/B,F/Azepine-5-carboxamide |
| 02/02/1999 | US5866565 Substituted-4-amino-3-pyridinols |
| 02/02/1999 | US5866563 Vanadium compositions |
| 02/02/1999 | US5866562 Ring-bridged bis-quinolines |
| 02/02/1999 | US5866561 Local delivery of estrogen for angiogenesis |
| 02/02/1999 | US5866559 Hormone replacement therapy; endometrioses |
| 02/02/1999 | US5866557 Use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 02/02/1999 | US5866556 Pyridinylbisphosphonates for use as a therapeutical agent |
| 02/02/1999 | US5866554 Drug mixture of hyaluronic acid, non-steroidal inflammatory drug and acid salt |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |
| 02/02/1999 | US5866550 Method of inhibiting replication of hyperproliferative cells using a nucleic acid encoding EIA |
| 02/02/1999 | US5866548 Caged membrane-permeant inositol phosphates |
| 02/02/1999 | US5866537 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 02/02/1999 | US5866536 Compounds and compositions for delivering active agents |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866377 Aminooligosaccharide derivative and process for preparing the same |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866369 Amps |
| 02/02/1999 | US5866366 gidB |
| 02/02/1999 | US5866329 Method and probe for detection of gene associated with liver neoplastic disease |
| 02/02/1999 | US5866318 Administering to nerve cells apopototic stimulant; calibration |
| 02/02/1999 | US5866298 Radiation sensitive composition for color filters |
| 02/02/1999 | US5866169 Lyophilized formulation with cisplatin; reduced side effects, increased antitumor activity |
| 02/02/1999 | US5866168 Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists |
| 02/02/1999 | US5866164 Composition and dosage form comprising opioid antagonist |
| 02/02/1999 | US5866161 Hydrocodone therapy |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866154 Parenteral drug autoclaved for sterilization |
| 02/02/1999 | US5866150 Antibacterially active extracts from the marine algae chaetoceros and methods of use |
| 02/02/1999 | US5866143 Topical application of opioid drugs such as morphine for relief of itching and skin disease |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | US5866120 Therapy for vision defects |
| 02/02/1999 | US5866105 Therapy for onychomycosis; topical applying nail varnish |
| 02/02/1999 | US5866074 Redox systems |
| 02/02/1999 | US5865784 Method of hemodilution facilitated by monitoring oxygenation status |
| 02/02/1999 | CA2130464C Topical aromatic releasing compositions |
| 02/02/1999 | CA2017916C Etoposide preparations |
| 02/02/1999 | CA1340369C Antisense oligonucleotides to c-myb proto-oncogene and uses thereof |
| 02/02/1999 | CA1340362C Thiadiazinones |
| 02/02/1999 | CA1340361C N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/31/1999 | CA2244200A1 Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 01/30/1999 | CA2244438A1 New benzimidazole, benzoxazole and benzothiazole derivatives, their preparation process and the pharmaceutical compositions containing them |